MOBI.US Mobia Medical, Inc. Common Stock
- Market cap
- USD 438M
- P/E
- -
- P/B
- 2.77x
- ROE
- -47.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is MOBI.US undervalued?
Graham numberThe Graham number of Mobia Medical, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Mobia Medical, Inc. Common Stock fundamental analysis
No fundamental analysis for Mobia Medical, Inc. Common Stock yet.
Mobia Medical, Inc. Common Stock stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Mobia Medical, Inc. Common Stock
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-st…
Full company profileMobia Medical, Inc. Common Stock financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Mobia Medical, Inc. Common Stock annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|
| Income Statement | |||
| Revenue | 15.6M | 32.0M | 54.9M |
| Gross Profit | 12.5M | 26.0M | 45.6M |
| Operating Income | -24.2M | -46.4M | -71.2M |
| EBITDA | -23.5M | -45.4M | -69.6M |
| Net Income | -24.6M | -46.5M | -74.8M |
| EPS | -0.74 | -1.41 | -2.25 |
| Balance Sheet | |||
| Total Assets | 22.1M | 48.1M | 181M |
| Total Liabilities | 128M | 199M | 23.3M |
| Shareholders' Equity | -106M | -151M | 158M |
| Cash & Short-term Investments | 14.6M | 33.6M | 161M |
| Total Debt | 7.72M | 8.44M | 8.37M |
| Cash Flow | |||
| Operating Cash Flow | -24.3M | -45.7M | -61.8M |
| Capital Expenditure | 40.8K | 364K | 2.19M |
| Free Cash Flow | -24.4M | -46.1M | -63.9M |
| Ratios | |||
| ROE | - | - | -47.4% |
| ROA | -111.4% | -96.6% | -41.3% |
| Net Profit Margin | -157.3% | -145.1% | -136.2% |
| Debt to Equity | - | - | 0.05x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Mobia Medical, Inc. Common Stock dividends
Mobia Medical, Inc. Common Stock has not paid dividends in the last 2 fiscal years.
Who owns Mobia Medical, Inc. Common Stock
- Insiders 8.57%
- Institutions 78.14%
- Public & others 13.29%
- Shares outstanding 33.3M
- Free float 13.8M
Top funds holding MOBI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| abrdn Healthcare Investors | 380K | 1.14% | +21.42% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 320K | 0.96% | 0.00% | Sep 2026 |
| abrdn Healthcare Opportunities | 315K | 0.95% | +25.56% | Sep 2026 |
| abrdn World Healthcare | 200K | 0.60% | +14.49% | Sep 2026 |
| iShares Russell 2000 ETF | 193K | 0.58% | 0.00% | Oct 2026 |
| Bellevue Digital Health I2 EUR | 117K | 0.35% | +16.87% | Sep 2026 |
| Vanguard Russell 2000 ETF | 56.6K | 0.17% | +376.38% | Sep 2026 |
| iShares Russell 2000 Growth ETF | 53.6K | 0.16% | -0.38% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 52.7K | 0.16% | +0.18% | Oct 2026 |
| Fidelity Extended Market Index | 49.5K | 0.15% | -0.38% | Sep 2026 |
| iShares Russell 2000 Value ETF | 29.8K | 0.09% | 0.00% | Oct 2026 |
| iShares Micro-Cap ETF | 29.0K | 0.09% | 0.00% | Oct 2026 |
| Schwab Small Cap Index | 23.7K | 0.07% | 0.00% | Sep 2026 |
| Fidelity Total Market Index | 22.3K | 0.07% | -0.05% | Sep 2026 |
| Fidelity Nasdaq Composite Index | 20.2K | 0.06% | 0.00% | Aug 2026 |
| Bridge Builder Small Cap Fund | 18.7K | 0.06% | 0.00% | Oct 2026 |
| iShares Russell 2000 Small-Cap Idx Instl | 18.0K | 0.05% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 15.9K | 0.05% | 0.00% | Sep 2026 |
| EA Bridgeway Ultra-Small Company Mkt ETF | 12.4K | 0.04% | 0.00% | Oct 2026 |
| Nuveen Small Cap Blend Idx R6 | 11.7K | 0.04% | 0.00% | Sep 2026 |
Top institutions holding MOBI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 1.99M | 5.97% | 0.00% | Jun 2026 |
| Farallon Capital Management, L.L.C. | 1.13M | 3.39% | 0.00% | Jun 2026 |
| Aberdeen Group PLC | 894K | 2.69% | +53.00% | Sep 2026 |
| Avidity Partners Management LP | 798K | 2.40% | 0.00% | Jun 2026 |
| Deerfield Management Co | 671K | 2.01% | 0.00% | Jun 2026 |
| Perceptive Advisors LLC | 524K | 1.57% | 0.00% | Jun 2026 |
| Vanguard Capital Management, LLC | 444K | 1.33% | 0.00% | Jun 2026 |
| Rock Springs Capital Management LP | 418K | 1.26% | 0.00% | Jun 2026 |
| Balyasny Asset Management LLC | 388K | 1.16% | 0.00% | Jun 2026 |
| Integral Health Asset Management, LLC | 250K | 0.75% | 0.00% | Jun 2026 |
| Schonfeld Strategic Advisors LLC | 177K | 0.53% | 0.00% | Jun 2026 |
| BlackRock Inc | 153K | 0.46% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 126K | 0.38% | 0.00% | Jun 2026 |
| Ghisallo Capital Management LLC | 125K | 0.38% | 0.00% | Jun 2026 |
| Bellevue Group AG | 100K | 0.30% | 0.00% | Jun 2026 |
| LMR Partners LLP | 70.0K | 0.21% | 0.00% | Jun 2026 |
| Two Sigma Investments LLC | 68.0K | 0.20% | 0.00% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 63.9K | 0.19% | 0.00% | Jun 2026 |
| State Street Corp | 54.9K | 0.16% | 0.00% | Jun 2026 |
| Scs Capital Management LLC | 50.0K | 0.15% | 0.00% | Jun 2026 |
Mobia Medical, Inc. Common Stock company profile
- Company name
- Mobia Medical, Inc. Common Stock
- Ticker
- MOBI.US
- Exchange
- USA Stocks
- Listed since
- May 8, 2026
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 167
- Fiscal year end
- December
- Address
- 2802 Flintrock Trace, Austin, TX, United States, 78738
- Phone
- (855) 628-9375
- Website
- mobia.com
About Mobia Medical, Inc. Common Stock
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
Mobia Medical, Inc. Common Stock management
9- Mr. Richard John FoustCEO, President & Director · born 1974
- Mr. Thomas Jordan Curnes II, M.B.A.Co-Founder · born 1979
- Mr. Nelson Bunker CurnesChief Financial Officer · born 1983
- Mr. Prashant B. RawatChief Operating Officer · born 1974
- Mr. Douglas T. EllisonChief Commercial Officer · born 1963
- Dr. Navzer Engineer M.D., Ph.D.Co-Founder & Chief Scientific Officer
- Mr. Chase C. Leavitt J.D.General Counsel & Corporate Secretary · born 1982
- Mr. Philip B. FreedVice President of Marketing
- Ms. Steffanie CookVice President of Human Resources